These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
505 related items for PubMed ID: 18679798
1. Docosahexaenoic acid induces apoptosis in lung cancer cells by increasing MKP-1 and down-regulating p-ERK1/2 and p-p38 expression. Serini S, Trombino S, Oliva F, Piccioni E, Monego G, Resci F, Boninsegna A, Picci N, Ranelletti FO, Calviello G. Apoptosis; 2008 Sep; 13(9):1172-83. PubMed ID: 18679798 [Abstract] [Full Text] [Related]
2. Mitogen-activated protein kinase phosphatase-1 in human breast cancer independently predicts prognosis and is repressed by doxorubicin. Rojo F, González-Navarrete I, Bragado R, Dalmases A, Menéndez S, Cortes-Sempere M, Suárez C, Oliva C, Servitja S, Rodriguez-Fanjul V, Sánchez-Pérez I, Campas C, Corominas JM, Tusquets I, Bellosillo B, Serrano S, Perona R, Rovira A, Albanell J. Clin Cancer Res; 2009 May 15; 15(10):3530-9. PubMed ID: 19417026 [Abstract] [Full Text] [Related]
3. Mitogen-activated protein kinase phosphatase-1 negatively regulates the expression of interleukin-6, interleukin-8, and cyclooxygenase-2 in A549 human lung epithelial cells. Turpeinen T, Nieminen R, Moilanen E, Korhonen R. J Pharmacol Exp Ther; 2010 Apr 15; 333(1):310-8. PubMed ID: 20089808 [Abstract] [Full Text] [Related]
4. Mitogen-activated protein kinase phosphatase-1 is overexpressed in non-small cell lung cancer and is an independent predictor of outcome in patients. Vicent S, Garayoa M, López-Picazo JM, Lozano MD, Toledo G, Thunnissen FB, Manzano RG, Montuenga LM. Clin Cancer Res; 2004 Jun 01; 10(11):3639-49. PubMed ID: 15173070 [Abstract] [Full Text] [Related]
5. Eicosapentaenoic acid and docosahexaenoic acid modulate mitogen-activated protein kinase activity in endothelium. Xue H, Wan M, Song D, Li Y, Li J. Vascul Pharmacol; 2006 Jun 01; 44(6):434-9. PubMed ID: 16616699 [Abstract] [Full Text] [Related]
6. Mitogen-activated protein kinase phosphatase-1 modulated JNK activation is critical for apoptosis induced by inhibitor of epidermal growth factor receptor-tyrosine kinase. Takeuchi K, Shin-ya T, Nishio K, Ito F. FEBS J; 2009 Mar 01; 276(5):1255-65. PubMed ID: 19175673 [Abstract] [Full Text] [Related]
7. Proteasome inhibitors induce a p38 mitogen-activated protein kinase (MAPK)-dependent anti-apoptotic program involving MAPK phosphatase-1 and Akt in models of breast cancer. Shi YY, Small GW, Orlowski RZ. Breast Cancer Res Treat; 2006 Nov 01; 100(1):33-47. PubMed ID: 16807678 [Abstract] [Full Text] [Related]
8. Mitogen-activated protein kinase phosphatase 1 is overexpressed in prostate cancers and is inversely related to apoptosis. Magi-Galluzzi C, Mishra R, Fiorentino M, Montironi R, Yao H, Capodieci P, Wishnow K, Kaplan I, Stork PJ, Loda M. Lab Invest; 1997 Jan 01; 76(1):37-51. PubMed ID: 9010448 [Abstract] [Full Text] [Related]
9. Sanguinarine induces apoptosis in A549 human lung cancer cells primarily via cellular glutathione depletion. Jang BC, Park JG, Song DK, Baek WK, Yoo SK, Jung KH, Park GY, Lee TY, Suh SI. Toxicol In Vitro; 2009 Mar 01; 23(2):281-7. PubMed ID: 19135517 [Abstract] [Full Text] [Related]
10. Cyclic AMP inhibits JNK activation by CREB-mediated induction of c-FLIP(L) and MKP-1, thereby antagonizing UV-induced apoptosis. Zhang J, Wang Q, Zhu N, Yu M, Shen B, Xiang J, Lin A. Cell Death Differ; 2008 Oct 01; 15(10):1654-62. PubMed ID: 18566605 [Abstract] [Full Text] [Related]
11. Mitogen-activated protein kinase phosphatase-1 is required for cisplatin resistance. Wang Z, Xu J, Zhou JY, Liu Y, Wu GS. Cancer Res; 2006 Sep 01; 66(17):8870-7. PubMed ID: 16951204 [Abstract] [Full Text] [Related]
12. Protein kinase Cdelta-mediated proteasomal degradation of MAP kinase phosphatase-1 contributes to glutamate-induced neuronal cell death. Choi BH, Hur EM, Lee JH, Jun DJ, Kim KT. J Cell Sci; 2006 Apr 01; 119(Pt 7):1329-40. PubMed ID: 16537649 [Abstract] [Full Text] [Related]
13. Cellular defense against H2O2-induced apoptosis via MAP kinase-MKP-1 pathway. Xu Q, Konta T, Nakayama K, Furusu A, Moreno-Manzano V, Lucio-Cazana J, Ishikawa Y, Fine LG, Yao J, Kitamura M. Free Radic Biol Med; 2004 Apr 15; 36(8):985-93. PubMed ID: 15059639 [Abstract] [Full Text] [Related]
14. Activation of nonsteroidal anti-inflammatory drug-activated gene-1 via extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase revealed a isochaihulactone-triggered apoptotic pathway in human lung cancer A549 cells. Chen YL, Lin PC, Chen SP, Lin CC, Tsai NM, Cheng YL, Chang WL, Lin SZ, Harn HJ. J Pharmacol Exp Ther; 2007 Nov 15; 323(2):746-56. PubMed ID: 17715378 [Abstract] [Full Text] [Related]
15. Possible involvement of mitogen-activated protein kinase phosphatase-1 (MKP-1) in thyrotropin-releasing hormone (TRH)-induced prolactin gene expression. Oride A, Kanasaki H, Purwana IN, Miyazaki K. Biochem Biophys Res Commun; 2009 May 15; 382(4):663-7. PubMed ID: 19289102 [Abstract] [Full Text] [Related]
16. Glutamine protects mice from lethal endotoxic shock via a rapid induction of MAPK phosphatase-1. Ko HM, Oh SH, Bang HS, Kang NI, Cho BH, Im SY, Lee HK. J Immunol; 2009 Jun 15; 182(12):7957-62. PubMed ID: 19494320 [Abstract] [Full Text] [Related]
17. Role of Rad51 down-regulation and extracellular signal-regulated kinases 1 and 2 inactivation in emodin and mitomycin C-induced synergistic cytotoxicity in human non-small-cell lung cancer cells. Su YJ, Tsai MS, Kuo YH, Chiu YF, Cheng CM, Lin ST, Lin YW. Mol Pharmacol; 2010 Apr 15; 77(4):633-43. PubMed ID: 20042515 [Abstract] [Full Text] [Related]
18. Mitogen-activated protein kinase phosphatase-1 is a mediator of breast cancer chemoresistance. Small GW, Shi YY, Higgins LS, Orlowski RZ. Cancer Res; 2007 May 01; 67(9):4459-66. PubMed ID: 17483361 [Abstract] [Full Text] [Related]
19. The decrease in JNK- and p38-MAP kinase activity is accompanied by the enhancement of PP2A phosphate level in the brain of prenatally stressed rats. Budziszewska B, Szymanska M, Leskiewicz M, Basta-Kaim A, Jaworska-Feil L, Kubera M, Jantas D, Lason W. J Physiol Pharmacol; 2010 Apr 01; 61(2):207-15. PubMed ID: 20436222 [Abstract] [Full Text] [Related]
20. Glucocorticoids inhibit IL-1beta-induced GM-CSF expression at multiple levels: roles for the ERK pathway and repression by MKP-1. Newton R, King EM, Gong W, Rider CF, Staples KJ, Holden NS, Bergmann MW. Biochem J; 2010 Mar 15; 427(1):113-24. PubMed ID: 20100175 [Abstract] [Full Text] [Related] Page: [Next] [New Search]